Skip to content

Medicine Matters

Sharing successes, challenges and daily happenings in the Department of Medicine

Medicine Matters Home › Article of the Week › Page 2

Article of the Week

Immunotherapy targeting drug-tolerant Mycobacterium tuberculosis persisters accelerates tuberculosis cure in preclinical models

ARTICLE: Immunotherapy targeting drug-tolerant Mycobacterium tuberculosis persisters accelerates tuberculosis cure in preclinical models AUTHORS: Styliani Karanika, Tianyin Wang, Addis Yilma, Jennie Ruelas Castillo, James T Gordy, Hannah Bailey, Darla Quijada, Kaitlyn Fessler, Rokeya… Read More »Immunotherapy targeting drug-tolerant Mycobacterium tuberculosis persisters accelerates tuberculosis cure in preclinical models

Selective targeting of HIV-infected clones by cognate peptide stimulation and antiproliferative drugs

ARTICLE: Selective targeting of HIV-infected clones by cognate peptide stimulation and antiproliferative drugs AUTHORS: Filippo Dragoni, Joel Sop, Isha Gurumurthy, Tyler P Beckey, Kellie N Smith, Francesco R Simonetti, Joel N… Read More »Selective targeting of HIV-infected clones by cognate peptide stimulation and antiproliferative drugs

Dynamics of natural and pharmacologic control of an SIV variant with an envelope trafficking defect

ARTICLE: Dynamics of natural and pharmacologic control of an SIV variant with an envelope trafficking defect AUTHORS: Kyle Rhodehouse, Carolin Zitzmann, Meghana Ravi, Ciara Armstrong, Milica Moskovljevic, Hannah P Moore, Courtney… Read More »Dynamics of natural and pharmacologic control of an SIV variant with an envelope trafficking defect

Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial

ARTICLE: Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in… Read More »Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial

Factors associated with resistance of HIV-1 reservoir viruses to neutralization by autologous IgG antibodies

ARTICLE: Factors associated with resistance of HIV-1 reservoir viruses to neutralization by autologous IgG antibodies AUTHORS: Natalie F McMyn, Joseph Varriale, Hanna W S Wu, Vivek Hariharan, Milica Moskovljevic, Toong… Read More »Factors associated with resistance of HIV-1 reservoir viruses to neutralization by autologous IgG antibodies

Budesonide-glycopyrronium-formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trials

ARTICLE: Budesonide-glycopyrronium-formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trials AUTHORS: Alberto Papi*, Robert A Wise*, David J… Read More »Budesonide-glycopyrronium-formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trials

Hepatotoxicity Among People With HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics

ARTICLE: Hepatotoxicity Among People With HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics AUTHORS: Grace Montepiedra, Lisa… Read More »Hepatotoxicity Among People With HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics